Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

HealthIntell Articles

  • Causes of Porphyria cutanea tarda

    Porphyria cutanea tarda is caused by reduced activity of the enzyme uroporphyrinogen decarboxylase, which disrupts heme production and leads to the buildup of photosensitive porphyrins in the body. In practical terms, the condition develops…

    Read article

  • Symptoms of Porphyria cutanea tarda

    Porphyria cutanea tarda produces a distinctive set of symptoms centered on the skin, especially on sun-exposed areas such as the backs of the hands, forearms, face, and ears. The most characteristic findings are fragile…

    Read article

  • What is Porphyria cutanea tarda

    Porphyria cutanea tarda is a disorder of heme metabolism in which the body does not process porphyrin precursors normally, leading to accumulation of light-sensitive compounds in the skin and other tissues. It is the…

    Read article

  • FAQ about Acute intermittent porphyria

    This FAQ explains acute intermittent porphyria, often called AIP, in clear practical terms. It covers what the condition is, why it happens, how it is diagnosed, what treatment looks like, and what people can…

    Read article

  • Prevention of Acute intermittent porphyria

    Acute intermittent porphyria (AIP) cannot usually be prevented in the strict sense because the underlying cause is inherited: a pathogenic variant in the gene encoding porphobilinogen deaminase, also called hydroxymethylbilane synthase. This enzyme defect…

    Read article

  • Diagnosis of Acute intermittent porphyria

    Acute intermittent porphyria (AIP) is usually identified through a combination of clinical suspicion and targeted biochemical testing. It is one of the acute porphyrias, a group of disorders caused by inherited defects in the…

    Read article

  • Treatment for Acute intermittent porphyria

    The treatments used for Acute intermittent porphyria are primarily aimed at stopping acute attacks, lowering the buildup of toxic porphyrin precursors, and preventing complications caused by the underlying enzyme defect. The main approaches include…

    Read article